GlassScriptPhysician profile
Christopher J Collazo
NPI 1386198976
$7,414.35
in general payments reported to CMS, 2019-2025
10 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2020: $1,139 · 2021: $29.35 · 2022: $1,181 · 2023: $3,323 · 2024: $775 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,425 · Food and Beverage: $1,322 · Consulting Fee: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,425.23 |
| Food and Beverage | $1,321.91 |
| Consulting Fee | $465.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,506.07 | 2019-2025 | Prophecy, Inbone, Invision |
| Medical Device Business Services, INC. | $2,358.01 | 2023-2024 | Motoband |
| Medline Industries LP | $727.81 | 2019-2023 | |
| Depuy Synthes Sales INC. | $579.21 | 2019-2025 | Hammerlock, Va-Lcp, Motoband |
| Horizon Therapeutics Plc | $103.33 | 2019 | |
| Abbott Laboratories | $43.93 | 2023-2024 | Proclaim |
| Orthofix Medical, INC. | $40.68 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $19.16 | 2025 | |
| Tei Medical INC. | $19.00 | 2019 | |
| Organogenesis INC. | $17.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Collazo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.